Results 71 to 80 of about 334,470 (291)

Oral Anticoagulation [PDF]

open access: yesDeutsches Ärzteblatt international, 2018
Much new evidence on oral anticoagulation has come to light in recent years. Non-vitamin-K-dependent oral anti- coagulants (NOAC) have been developed and have been introduced into clinical practice. In this review, we present the current state of the evidence on anticoagulation for various indications with vitamin K antagonists (VKA) and with NOAC.This
Ertunc, Altiok, Nikolaus, Marx
openaire   +2 more sources

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

open access: yesBlood, 2020
Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy.
D. Tremblay   +18 more
semanticscholar   +1 more source

Clinical characteristics, management strategies and outcomes of patients with recurrent venous thromboembolism in the real world

open access: yesScientific Reports, 2022
There is a paucity of data on management strategies and clinical outcomes after recurrent venous thromboembolism (VTE). In a multicenter registry enrolling 3027 patients with acute symptomatic VTE, the current study population was divided into the ...
Yugo Yamashita   +22 more
doaj   +1 more source

Discrepancy between international normalized ratio measurements in a heterozygous carrier of F10:p.Gly244Arg with recurrent venous thromboembolism: a case report

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: The international normalized ratio (INR) is designed to monitor vitamin K antagonist (VKA) treatment. Before patients start a self-managing VKA program, parallel measurements are conducted to compare point-of-care testing (POCT) INR with ...
Nikolaj Julian Skrøder Nytofte   +1 more
doaj   +1 more source

Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study

open access: yesJournal of Neurology Neurosurgery & Psychiatry, 2021
Background and purpose A subset of ischaemic stroke patients with atrial fibrillation (AF) have ischaemic stroke despite anticoagulation. We sought to determine the association between prestroke anticoagulant therapy and recurrent ischaemic events and ...
S. Yaghi   +31 more
semanticscholar   +1 more source

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

open access: yesAmerican journal of hematology/oncology, 2019
Two specific reversal agents for direct oral anticoagulants (DOACs) have been approved in the United States: idarucizumab for dabigatran reversal and andexanet alfa for apixaban and rivaroxaban reversal.
A. Cuker   +7 more
semanticscholar   +1 more source

Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

open access: yesEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2021
Background The clinical impact of different prophylactic anticoagulation regimens among hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear.
L. Ortega‐Paz   +11 more
semanticscholar   +1 more source

Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19

open access: yesJAMA Network Open, 2021
Key Points Question What is the frequency with which patients hospitalized with COVID-19 are treated with venous thromboembolism (VTE) prophylactic- and treatment-dose anticoagulation, and what is the association of anticoagulation with in-hospital and ...
Valerie M. Vaughn   +8 more
semanticscholar   +1 more source

Monitorização da terapêutica com anticoagulantes orais. Consulta de anticoagulação vs médico assistente.

open access: yesActa Médica Portuguesa, 2004
Most patients on chronic oral anticoagulant therapy are monitored through anticoagulation clinics, or rather by assistant physicians. Our aim was to compare warfarin anticoagulated patients who were treated with usual medical care (assistant physician ...
Rui Barreira   +6 more
doaj   +1 more source

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation

open access: yesFrontiers in Pharmacology, 2023
Background: Oral anticoagulants (OACs) are essential for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the appropriateness of anticoagulation treatment in locally practice remains unclear.
Xiao-Yuan Zheng   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy